Filana Therapeutics, Inc. (FLNA) Free cash flow 2016–2025
Filana Therapeutics, Inc. (FLNA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.8MFY2025 · since FY2016: -$12.3M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | +71.9% |
| FY2024 | -$117.0M | -42.0% |
| FY2023 | -$82.4M | -2.8% |
| FY2022 | -$80.2M | -53.1% |
| FY2021 | -$52.4M | — |
| FY2019 | -$2.5M | — |
| FY2016 | -$12.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More FLNA financial trends
FLNA RevenueFLNA Net incomeFLNA Net marginFLNA Gross profitFLNA Gross marginFLNA Operating incomeFLNA Operating marginFLNA Operating cash flowFLNA Capital expendituresFLNA Return on equityFLNA Stock buybacksFLNA Dividends paidFLNA Total assetsFLNA Total liabilitiesFLNA Shareholders’ equityFLNA overview →